pharma Agustín Rullán, Dean of the College of Engineering at UPR Mayagüez, discusses the institution’s latest developments in engineering courses and their applicability in a practical industrial setting for students to jumpstart their professional careers. As a leading engineering college with 4,300 undergraduates and 400 graduates, the College plays a very…
pharma Jörg Buck, the Executive Director of the Italian-German Chamber of Commerce discusses the close trade relationship which ties the two countries together, how the business environment in Italy is evolving today and the need to keep the momentum in the economic recovery. To start off, having joined the chamber recently,…
Pharma The owner of Altis Biologics, Nick Duneas, illustrates the significance of the company’s flagship product, the Altis Osteogenic Bone Matrix (OBM) and how the company plans to commercialize the injectable bone graft substitute on a domestic and international scale moving forward. He also highlights how the Innovation Prize for Africa has…
Pharma The CEO of Diaxonhit Group, a fully integrated French leader in in vitro diagnostics, discusses the company’s strategic focus on specialty vitro diagnostics, his perspective on the challenge of consolidation that the diagnostics industry faces, as well as his cautiously optimistic assessment of French competitiveness in the pharmaceutical and life…
pharma The Director of the CNCR and the person in charge of the industrial sector, talk about the fragmented nature of French clinical research funding, why when it comes to boosting France’s attractiveness as a clinical research destination, funding is the number one issue for hospitals and reveals how the number…
France The President of France’s Association for CROs (AFCROs) discusses the issues surrounding France’s clinical research sector and the actions that both the public and private sector need to take to maintain their competitiveness. He also discusses his company’s recent merger with Biostatem and their mission to internationalize. While France remains…
France The Head of the Department of Medicine at the Faculty of Health Science at the University of Cape Town reveals how their role is not only in training people to be technically competent, but to produce the next generation of thinkers, researchers and innovators, how The Lancet report, produced by…
France The President and the Counselor of the French Chamber of Commerce and Industry in Egypt, discuss plans to establish a French industrial zone in Alexandria (North of Egypt) to further attract French FDI, and furthermore highlight the unique French-Egyptian relationship. Could you please introduce us to the French-Egyptian relationship? Mahmoud…
France PharmaBoardroom spoke to Fabrice Chouraqui, President of Novartis Latin America and Canada at the Financial Times LatAm Healthcare & Life Sciences Summit in September 2015. He emphasizes the criticality of access to innovation for patients in one of the world’s fastest-growing regions. You were appointed President of Novartis Latin America…
France The president of Gedeon Richter France and CEO of PregLem, a Swiss-based biotech company acquired by Gedeon Richter in 2010, discusses the exciting synergies that have emerged from this partnership in the past few years, her perspective on market access in France and the challenges and opportunities she has faced…
pharma The CEO and founder of ModiQuest discusses how, with its unique, fully-integrated antibody generation and development platform, the company is developing antibodies for potentially groundbreaking therapies for the prevention and treatment of rheumatoid arthritis and growing its already well-established CRO arm serving clients from around the world. Could you introduce…
pharma The general manager of Ferring South Africa, Mercia Van Zyl discusses the company’s ambitious plans for the future under the slogan ‘People come first’, the placement of fertility under the nation’s therapeutic priorities, and how the company is contributing to an overall better healthcare system in the country. Could you…
See our Cookie Privacy Policy Here